Inventor
MURASE KATSUYUKI
US12 patents
⚠️ This page may combine multiple inventors who share the name “MURASE KATSUYUKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT CARDIOVASCULAR SYSTEMS
6 patentsUS8383592B2Feb 26, 2013
Apo A-I mimetic peptides and methods of treatment
ABBOTT CARDIOVASCULAR SYSTEMS6 citations83
US8044021B2Oct 25, 2011
Sustained release of apo A-I mimetic peptides and methods of treatment
ABBOTT CARDIOVASCULAR SYSTEMS9 citations83
US8895056B2Nov 25, 2014
Regional delivery of therapeutic agents for the treatment of vascular diseases
ABBOTT CARDIOVASCULAR SYSTEMS2 citations62
US8748394B2Jun 10, 2014
Apo A-I mimetic peptides and methods of treatment
ABBOTT CARDIOVASCULAR SYSTEMS2 citations62
US7985727B1Jul 26, 2011
Apo A-I mimetic peptides and methods of treatment
ABBOTT CARDIOVASCULAR SYSTEMS2 citations62
US7985728B1Jul 26, 2011
Sustained release of Apo A-I mimetic peptides and methods of treatment
ABBOTT CARDIOVASCULAR SYSTEMS1 citations50
MURASE KATSUYUKI
4 patentsUS8709472B1Apr 29, 2014
Bioactive agent-loaded heart-targeting nanoparticles
MURASE KATSUYUKI8 citations82
US9173890B2Nov 3, 2015
Sustained release of Apo A-I mimetic peptides and methods of treatment
MURASE KATSUYUKI2 citations61
US8101565B2Jan 24, 2012
Sustained release of Apo A-I mimetic peptides and methods of treatment
MURASE KATSUYUKI2 citations61
US8735344B2May 27, 2014
Sustained release of APO A-I mimetic peptides and methods of treatment
MURASE KATSUYUKI0 citations49